Protein encapsulation in liposomes: Efficiency depends on interactions between protein and phospholipid bilayer

被引:225
作者
Colletier J.-P. [1 ,2 ]
Chaize B. [1 ,2 ]
Winterhalter M. [2 ]
Fournier D. [1 ]
机构
[1] Lab. Synthese/Physicochimie Molec., Groupe de Biochimie des Proteines, Université Paul Sabatier, Toulouse
[2] Inst. Pharmacol. Biol. Structurale, Lab. de Biophysique Membranaire, Toulouse
关键词
Encapsulation; Encapsulation Efficiency; AChE Activity; Lipid Concentration; Lipid Film;
D O I
10.1186/1472-6750-2-9
中图分类号
学科分类号
摘要
Background: We investigated the encapsulation mechanism of enzymes into liposomes. The existing protocols to achieve high encapsulation efficiencies are basically optimized for chemically stable molecules. Enzymes, however, are fragile and encapsulation requires in addition the preservation of their functionality. Using acetylcholinesterase as a model, we found that most protocols lead to a rapid denaturation of the enzyme with loss in the functionality and therefore inappropriate for such an application. The most appropriate method is based on lipid film hydration but had a very low efficiency. Results: To improve it and to propose a standard procedure for enzyme encapsulation, we separate each step and we studied the effect of each parameter on encapsulation: lipid and buffer composition and effect of the different physical treatment as freeze-thaw cycle or liposomes extrusion. We found that by increasing the lipid concentration, increasing the number of freezethaw cycles and enhancing the interactions of the enzyme with the liposome lipid surface more than 40% of the initial total activity can be encapsulated. Conclusion: We propose here an optimized procedure to encapsulate fragile enzymes into liposomes. Optimal encapsulation is achieved by induction of a specific interaction between the enzyme and the lipid surface. © 2002 Colletier et al; licensee BioMed Central Ltd.
引用
收藏
页数:8
相关论文
共 17 条
[1]
Nasseau M., Boublik Y., Meier W., Winterhalter M., Fournier D., Substrate-permeable encapsulation of enzymes maintains effective activity, stabilizes against denaturation, and protects against proteolytic degradation, Biotech. Bioeng., 75, pp. 615-618, (2001)
[2]
Nardin C., Thoeni S., Widmer J., Winterhalter M., Meier W., Nanoreactors based on polymerised-ABA triblock copolymer vesicles, Chem. Comm., pp. 1433-1434, (2000)
[3]
Gregoriadis G., Engineering liposomes for drug delivery: Progress and problems, TIBTECH, 13, pp. 527-537, (1995)
[4]
Van Slooten M.L., Boerman O., RomOren K., Kedar E., Crommelin D.J.A., Storm A., Liposomes as sustained release system for human interferon-γ: Biopharmaceutical aspects, Biochim. Biophys. Acta, 1530, pp. 134-145, (2001)
[5]
Graff A., Winterhalter M., Meier W., Nanoreactors from Polymer Stabilized Liposomes, Langmuir, 17, pp. 919-923, (2001)
[6]
Nardin C., Winterhalter M., Meier W., Reconstitution of channel proteins in polymerised-ABA triblock copolymer membranes, Angew Chemie, 39, pp. 4599-4602, (2000)
[7]
Moscho A., Orwar O., Chiu D.T., Modi B.P., Zaren R.N., Rapid preparation of giant unilamellar vesicles, Proc. Natl. Acad. Sci. USA, 93, pp. 11443-11447, (1996)
[8]
Lichtenberg D., Barenholtz Y., Liposomes:preparation, characterization and preservation, Methods Biochem. Anal., 33, pp. 337-462, (1988)
[9]
Kirby C., Gregoriadis G., Preparation of liposomes containing factor VII for oral treatment of hemophilia, J. Microencapsul, 1, pp. 33-45, (1984)
[10]
Anselem S., Gabizon A., Barenholz Y., Gregoriadis G., Liposome Technology, (1993)